LONDON and WILMINGTON, North Carolina, May 28, 2014 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), today announced the appointment of Michael Wisniewski, PhD as Sr. Executive Director, Biometrics to lead Chiltern's global Biostatistics team and provide expertise and consultancy to Chiltern clients.
Alecia Barbee, Chiltern's Vice President, Global Biometrics offered: "We are very excited to have Dr. Wisniewski join Chiltern to oversee our global Biostatistics and Statistical Programming groups. Michael brings an outstanding mix of Pharma, CRO, and academia experiences that will help Chiltern continue to advance our industry-leading biometrics service offerings."
With 30 years industry experience, Dr. Wisniewski joins Chiltern as a leader in product development, including over 23 years at Glaxo SmithKline as Executive Director of Clinical Statistics and Programming. He is widely published in oncology and respiratory topics and has been involved in 11 regulatory submissions to FDA and other agencies leading to marketing approval.
Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs more than 1,600 people globally and offers services in Global Clinical Development, Global Scientific Services, and Global Resourcing Solutions. Chiltern prides itself as a development partner that offers innovation, responsiveness and quality delivery.
Further information is available at: www.chiltern.com.
For more information contact:
Sr. Director, Global Commercial Affairs
Chiltern International Inc.
2528 Independence Blvd. Suite 101
Wilmington, NC 28412
Tel: +1 (910) 338 4760